BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Testicular cancer AND NRAS, N-ras, 4893, ENSG00000213281, P01111, NRAS1
27 results:

  • 1. Evolution of testicular Germ Cell Tumors in the Molecular Era With Histogenetic Implications.
    Kilic I; Acosta AM; Idrees MT
    Adv Anat Pathol; 2024 May; 31(3):206-214. PubMed ID: 38525515
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Comprehensive characteristics of pathological subtypes in testicular germ cell tumor: Gene expression, mutation and alternative splicing.
    Yao X; Zhou H; Duan C; Wu X; Li B; Liu H; Zhang Y
    Front Immunol; 2022; 13():1096494. PubMed ID: 36713456
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Cumulative incidence and risk factors of brain metastasis for acral and mucosal melanoma patients with stages I-III.
    Wang Y; Lian B; Si L; Mao L; Chi Z; Sheng X; Kong Y; Wang X; Bai X; Yan X; Li S; Tang B; Dai J; Zhou L; Wei X; Cui C; Guo J
    Eur J Cancer; 2022 Nov; 175():196-203. PubMed ID: 36137395
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Genetics of testicular cancer: a review.
    Martin FC; Conduit C; Loveland KL; Thomas B; Lewin J; Tran B
    Curr Opin Urol; 2022 Sep; 32(5):481-487. PubMed ID: 35855571
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Molecular assessment of testicular adult granulosa cell tumor demonstrates significant differences when compared to ovarian counterparts.
    Siegmund S; Sholl LM; Cornejo KM; Sangoi AR; Otis CN; Mehra R; Hirsch MS; Acosta AM
    Mod Pathol; 2022 May; 35(5):697-704. PubMed ID: 34845303
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. RAS/MAPK Pathway Driver Alterations Are Significantly Associated With Oncogenic KIT Mutations in Germ-cell Tumors.
    Mata DA; Yang SR; Ferguson DC; Liu Y; Sharma R; Benhamida JK; Al-Ahmadie HA; Chakravarty D; Solit DB; Tickoo SK; Gupta S; Arcila ME; Ladanyi M; Feldman DR; Reuter VE; Vanderbilt CM
    Urology; 2020 Oct; 144():111-116. PubMed ID: 32721511
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Cost-effectiveness Analysis of Non-risk-adapted Active Surveillance for Postorchiectomy Management of Clinical Stage I Seminoma.
    Huang MM; Su ZT; Cheaib JG; Biles MJ; Allaf ME; Patel HD; Pierorazio PM
    Eur Urol Focus; 2021 Nov; 7(6):1409-1417. PubMed ID: 32646809
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Comprehensive characterization of cancer-testis genes in testicular germ cell tumor.
    Chang Y; Wang X; Xu Y; Yang L; Qian Q; Ju S; Chen Y; Chen S; Qin N; Ma Z; Dai J; Ma H; Jin G; Zhang E; Wang C; Hu Z
    Cancer Med; 2019 Jul; 8(7):3511-3519. PubMed ID: 31070303
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Genetics of testicular germ cell tumors.
    Singla N; Lafin JT; Ghandour RA; Kaffenberger S; Amatruda JF; Bagrodia A
    Curr Opin Urol; 2019 Jul; 29(4):344-349. PubMed ID: 31045925
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Integrated Molecular Characterization of testicular Germ Cell Tumors.
    Shen H; Shih J; Hollern DP; Wang L; Bowlby R; Tickoo SK; Thorsson V; Mungall AJ; Newton Y; Hegde AM; Armenia J; Sánchez-Vega F; Pluta J; Pyle LC; Mehra R; Reuter VE; Godoy G; Jones J; Shelley CS; Feldman DR; Vidal DO; Lessel D; Kulis T; Cárcano FM; Leraas KM; Lichtenberg TM; Brooks D; Cherniack AD; Cho J; Heiman DI; Kasaian K; Liu M; Noble MS; Xi L; Zhang H; Zhou W; ZenKlusen JC; Hutter CM; Felau I; Zhang J; Schultz N; Getz G; Meyerson M; Stuart JM; ; Akbani R; Wheeler DA; Laird PW; Nathanson KL; Cortessis VK; Hoadley KA
    Cell Rep; 2018 Jun; 23(11):3392-3406. PubMed ID: 29898407
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Non-risk-adapted Surveillance for Stage I testicular cancer: Critical Review and Summary.
    Pierorazio PM; Albers P; Black PC; Tandstad T; Heidenreich A; Nicolai N; Nichols C
    Eur Urol; 2018 Jun; 73(6):899-907. PubMed ID: 29338978
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Whole-genome sequencing of spermatocytic tumors provides insights into the mutational processes operating in the male germline.
    Giannoulatou E; Maher GJ; Ding Z; Gillis AJM; Dorssers LCJ; Hoischen A; Rajpert-De Meyts E; ; McVean G; Wilkie AOM; Looijenga LHJ; Goriely A
    PLoS One; 2017; 12(5):e0178169. PubMed ID: 28542371
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. K-RAS and n-ras mutations in testicular germ cell tumors.
    Hacioglu BM; Kodaz H; Erdogan B; Cinkaya A; Tastekin E; Hacibekiroglu I; Turkmen E; Kostek O; Genc E; Uzunoglu S; Cicin I
    Bosn J Basic Med Sci; 2017 May; 17(2):159-163. PubMed ID: 28426398
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Presence of somatic mutations within PIK3CA, AKT, RAS, and FGFR3 but not BRAF in cisplatin-resistant germ cell tumors.
    Feldman DR; Iyer G; Van Alstine L; Patil S; Al-Ahmadie H; Reuter VE; Bosl GJ; Chaganti RS; Solit DB
    Clin Cancer Res; 2014 Jul; 20(14):3712-20. PubMed ID: 24812411
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. CD133 is indicative for a resistance phenotype but does not represent a prognostic marker for survival of non-small cell lung cancer patients.
    Salnikov AV; Gladkich J; Moldenhauer G; Volm M; Mattern J; Herr I
    Int J Cancer; 2010 Feb; 126(4):950-8. PubMed ID: 19676044
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. KIT and RAS signalling pathways in testicular germ cell tumours: new data and a review of the literature.
    Goddard NC; McIntyre A; Summersgill B; Gilbert D; Kitazawa S; Shipley J
    Int J Androl; 2007 Aug; 30(4):337-48; discussion 349. PubMed ID: 17573850
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. DNA repair capacity and cisplatin sensitivity of human testis tumour cells.
    Köberle B; Grimaldi KA; Sunters A; Hartley JA; Kelland LR; Masters JR
    Int J Cancer; 1997 Mar; 70(5):551-5. PubMed ID: 9052754
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Cellular genes possibly involved in the transformation process of the human melanoma cell line XP44 RO (Mel).
    Lafarge-Frayssinet C; Daya-Grosjean L; Estrade S; Frezouls G; Sarasin A; Cassingena R
    Anticancer Res; 1995; 15(4):1205-13. PubMed ID: 7654000
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. N- and KRAS mutations in primary testicular germ cell tumors: incidence and possible biological implications.
    Olie RA; Looijenga LH; Boerrigter L; Top B; Rodenhuis S; Langeveld A; Mulder MP; Oosterhuis JW
    Genes Chromosomes Cancer; 1995 Feb; 12(2):110-6. PubMed ID: 7535083
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Differential expression of protooncogenes in human germ cell tumors of the testis.
    Shuin T; Misaki H; Kubota Y; Yao M; Hosaka M
    Cancer; 1994 Mar; 73(6):1721-7. PubMed ID: 7908857
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.